In a recent study posted to the bioRxiv* server, researchers assessed the immunogenicity of the self-developed recombinant adenovirus vector (rAd5) vaccine on macaques. They evaluated the efficacy of ...

The causative agent of the coronavirus disease 2019 (COVID-19) – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – was first detected in Wuhan, China, in December 2019. To date, the virus ...

Bristol Myers Squibb’s cancer cell therapy Breyanzi. Johnson & Johnson and AstraZeneca’s recombinant COVID-19 vaccines. Novartis’ gene therapy Zolgensma. All of these, plus many others, are united by ...

The recombinant vector vaccines segment accounted for a market share of more than 11% in the global veterinary market in 2016. Recombinant vector vaccines mimic a natural process of infection, but ...

There's good news about coronavirus vaccines. At least three of the experimental vaccines show remarkable efficacy, at least according to information released by the makers in news releases. Global ...

A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The study found ...

Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation PURPOSE: A phase I clinical trial in patients with advanced carcinoma was conducted, using a ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Shingles Vaccine Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The shingles vaccine market size has grown rapidly in ...

The U.S. Food & Drug Administration and U.S. Centers for Disease Control and Prevention recommended a pause in giving shots of the one-dose Johnson & Johnson COVID-19 vaccine Tuesday because severe ...

The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR ...